KEDPLASMA USA, established in 2004, specializes in the collection and procurement of high-quality plasma that is processed into plasma-based therapies. With over 900 employees, KEDPLASMA USA operates over 25 plasma centers in the United States.
KEDPLASMA is a subsidiary of Kedrion Biopharma, an international company that produces and distributes plasma-derived medicinal products for use in treating severe diseases, disorders and conditions such as hemophilia and immune system deficiencies.
